{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:43:10Z","timestamp":1790768590793,"version":"4.1.0"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2010,3,9]],"date-time":"2010-03-09T00:00:00Z","timestamp":1268092800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0000595","type":"journal-article","created":{"date-parts":[[2010,3,8]],"date-time":"2010-03-08T18:09:54Z","timestamp":1268071794000},"page":"e595","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":157,"title":["Rabies-Specific Antibodies: Measuring Surrogates of Protection against a Fatal Disease"],"prefix":"10.1371","volume":"4","author":[{"given":"Susan M.","family":"Moore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathleen A.","family":"Hanlon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2010,3,9]]},"reference":[{"key":"ref1","first-page":"535","article-title":"A rapid reproducible test for determining rabies neutralizing antibody.","volume":"48","author":"JS Smith","year":"1973","journal-title":"Bull World Health Organ"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"735","DOI":"10.20506\/rst.11.3.622","article-title":"Practical significance of rabies antibodies in cats and dogs.","volume":"11","author":"MF Aubert","year":"1992","journal-title":"Rev Sci Tech"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1128\/JVI.72.5.3711-3719.1998","article-title":"Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system.","volume":"72","author":"DC Hooper","year":"1998","journal-title":"J Virol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0966-842X(93)90035-P","article-title":"Antibody-mediated clearance of viruses from the mammalian central nervous system.","volume":"1","author":"B Dietzschold","year":"1993","journal-title":"Trends Microbiol"},{"key":"ref5","first-page":"28","article-title":"Characteristics and molecular biology of the rabies virus.","author":"N Tordo","year":"1996"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1073\/pnas.88.5.2001","article-title":"Rabies virus nucleoprotein expressed in and purified from insect cells is efficacious as a vaccine.","volume":"88","author":"ZF Fu","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1099\/0022-1317-83-12-3045","article-title":"Studies on the different conditions for rabies virus neutralization by monoclonal antibodies #1-46-12 and #7-1-9.","volume":"83","author":"T Irie","year":"2002","journal-title":"J Gen Virol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1006\/viro.1993.1261","article-title":"Mechanisms of rabies virus neutralization.","volume":"194","author":"A Flamand","year":"1993","journal-title":"Virology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature06106","article-title":"Fc receptor but not complement binding is important in antibody protection against HIV.","volume":"449","author":"AJ Hessell","year":"2007","journal-title":"Nature"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.2460\/ajvr.2002.63.1096","article-title":"Postexposure prophylaxis for prevention of rabies in dogs.","volume":"63","author":"CA Hanlon","year":"2002","journal-title":"Am J Vet Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/j.vaccine.2005.12.003","article-title":"How far can the antigen content of tissue culture rabies vaccine be reduced safely?","volume":"24","author":"J Beran","year":"2006","journal-title":"Vaccine"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1016\/S0264-410X(00)00054-2","article-title":"Predictive factors for the neutralizing antibody response following pre-exposure rabies immunization: validation of a new booster dose strategy.","volume":"18","author":"C Strady","year":"2000","journal-title":"Vaccine"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s00251-004-0756-0","article-title":"HLA class II alleles and measles virus-specific cytokine immune response following two doses of measles vaccine.","volume":"56","author":"IG Ovsyannikova","year":"2005","journal-title":"Immunogenetics"},{"key":"ref14","first-page":"160","article-title":"Early\/High and Late\/Low Responders among HDCS Vaccinees.","author":"EK Kuwert","year":"1981"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s00705-006-0923-8","article-title":"Neutralization of animal virus infectivity by antibody.","volume":"152","author":"SA Reading","year":"2007","journal-title":"Arch Virol"},{"key":"ref16","first-page":"246","article-title":"Pathogenesis.","author":"AC Jackson","year":"2002"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.virusres.2008.10.009","article-title":"Effect of cellular cholesterol depletion on rabies virus infection.","volume":"139","author":"K Hotta","year":"2009","journal-title":"Virus Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/infdis\/148.3.610","article-title":"Persistence of rabies antibody in free-ranging raccoons.","volume":"148","author":"WJ Bigler","year":"1983","journal-title":"J Infect Dis"},{"key":"ref19","first-page":"201","article-title":"Rabies in terrestrial animals.","author":"CA Hanlon","year":"2007"},{"key":"ref20","first-page":"200","article-title":"Competitive ELISA for the detection of rabies virus neutralizing antibodies.","author":"LD Elmgren","year":"1996"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1128\/JCM.38.4.1397-1403.2000","article-title":"A panel of monoclonal antibodies targeting the rabies virus phosphoprotein identifies a highly variable epitope of value for sensitive strain discrimination.","volume":"38","author":"SA Nadin-Davis","year":"2000","journal-title":"J Clin Microbiol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1099\/vir.0.2008\/000349-0","article-title":"Investigating antibody neutralization of lyssaviruses using lentiviral pseudotypes: a cross-species comparison.","volume":"89","author":"E Wright","year":"2008","journal-title":"J Gen Virol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/nri891","article-title":"Antibodies, viruses and vaccines.","volume":"2","author":"DR Burton","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"ref24","volume":"824","year":"1992"},{"key":"ref25","first-page":"1","article-title":"Human Rabies Prevention --- United States, 2008.","volume":"57","year":"2008"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0195-5616(01)50610-5","article-title":"Importation of dogs and cats to rabies-free areas of the world.","volume":"31","author":"DJ Briggs","year":"2001","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1099\/jmm.0.006064-0","article-title":"An evaluation of two commercially available ELISAs and one in-house reference laboratory ELISA for the determination of human anti-rabies virus antibodies.","volume":"58","author":"RJ Welch","year":"2009","journal-title":"J Med Microbiol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0022-1759(97)00212-3","article-title":"Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibody.","volume":"212","author":"F Cliquet","year":"1998","journal-title":"J Immunol Methods"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1128\/JCM.27.5.899-902.1989","article-title":"Enzyme-linked immunosorbent assay for determination of antibodies to the envelope glycoprotein of rabies virus.","volume":"27","author":"M Grassi","year":"1989","journal-title":"J Clin Microbiol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1128\/JVI.79.8.4672-4678.2005","article-title":"Novel rabies virus-neutralizing epitope recognized by human monoclonal antibody: fine mapping and escape mutant analysis.","volume":"79","author":"WE Marissen","year":"2005","journal-title":"J Virol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.virol.2008.02.007","article-title":"Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccination.","volume":"375","author":"VR Polonis","year":"2008","journal-title":"Virology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.biologicals.2005.06.005","article-title":"The influence of homologous vs. heterologous challenge virus strains on the serological test results of rabies virus neutralizing assays.","volume":"33","author":"SM Moore","year":"2005","journal-title":"Biologicals"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0092-1157(75)90030-X","article-title":"A collaborative study on the potency testing of antirabies globulin.","volume":"3","author":"EA Fitzgerald","year":"1975","journal-title":"J Biol Stand"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0092-1157(85)80047-0","article-title":"A collaborative study to establish an International Standard Rabies immunoglobulin of human origin.","volume":"13","author":"EA Fitzgerald","year":"1985","journal-title":"J Biol Stand"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1045-1056(05)80051-X","article-title":"Rabies vaccine standardization: International Collaborative Study for the Characterization of the fifth International Standard for Rabies Vaccine.","volume":"20","author":"J Lyng","year":"1992","journal-title":"Biologicals"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1006\/biol.1994.1036","article-title":"Calibration of a replacement preparation for the International Standard for Rabies Immunoglobulin.","volume":"22","author":"J Lyng","year":"1994","journal-title":"Biologicals"}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0000595","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T13:09:27Z","timestamp":1591103367000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0000595"}},"subtitle":[],"editor":[{"given":"Jeffrey M.","family":"Bethony","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2010,3,9]]},"references-count":36,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2010,3,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0000595","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,9]]}}}